nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—CYP2C9—brain cancer	0.495	1	CbGaD
Carbamazepine—CYP1A2—Carmustine—brain cancer	0.0509	0.178	CbGbCtD
Carbamazepine—ABCC2—Carboplatin—brain cancer	0.0482	0.168	CbGbCtD
Carbamazepine—ABCC2—Etoposide—brain cancer	0.0405	0.141	CbGbCtD
Carbamazepine—CYP3A4—Temozolomide—brain cancer	0.0385	0.134	CbGbCtD
Carbamazepine—CYP3A4—Lomustine—brain cancer	0.0327	0.114	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—brain cancer	0.0203	0.0707	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—brain cancer	0.0195	0.068	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—brain cancer	0.0151	0.0526	CbGbCtD
Carbamazepine—ABCB1—Etoposide—brain cancer	0.0132	0.046	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—brain cancer	0.0079	0.0276	CbGbCtD
Carbamazepine—Oxaprozin—CYP2C9—brain cancer	0.000835	0.333	CrCbGaD
Carbamazepine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000779	0.0157	CbGpPWpGaD
Carbamazepine—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000761	0.0153	CbGpPWpGaD
Carbamazepine—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000732	0.0148	CbGpPWpGaD
Carbamazepine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000659	0.0133	CbGpPWpGaD
Carbamazepine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000634	0.0128	CbGpPWpGaD
Carbamazepine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000588	0.0119	CbGpPWpGaD
Carbamazepine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000566	0.0114	CbGpPWpGaD
Carbamazepine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000535	0.0108	CbGpPWpGaD
Carbamazepine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000522	0.0105	CbGpPWpGaD
Carbamazepine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000509	0.0103	CbGpPWpGaD
Carbamazepine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000458	0.00924	CbGpPWpGaD
Carbamazepine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000441	0.00889	CbGpPWpGaD
Carbamazepine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000437	0.00881	CbGpPWpGaD
Carbamazepine—Modafinil—CYP2C9—brain cancer	0.000432	0.172	CrCbGaD
Carbamazepine—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000431	0.0087	CbGpPWpGaD
Carbamazepine—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000431	0.00868	CbGpPWpGaD
Carbamazepine—RALBP1—Rho GTPase cycle—VAV1—brain cancer	0.000427	0.00861	CbGpPWpGaD
Carbamazepine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000404	0.00814	CbGpPWpGaD
Carbamazepine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000394	0.00795	CbGpPWpGaD
Carbamazepine—Phenytoin—CYP2C9—brain cancer	0.000383	0.153	CrCbGaD
Carbamazepine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000376	0.00757	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000365	0.00736	CbGpPWpGaD
Carbamazepine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000354	0.00714	CbGpPWpGaD
Carbamazepine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000354	0.00713	CbGpPWpGaD
Carbamazepine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00034	0.00686	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—VAV1—brain cancer	0.000331	0.00668	CbGpPWpGaD
Carbamazepine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000323	0.00652	CbGpPWpGaD
Carbamazepine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000319	0.00643	CbGpPWpGaD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000317	0.00638	CbGpPWpGaD
Carbamazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000316	0.00637	CbGpPWpGaD
Carbamazepine—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000312	0.00629	CbGpPWpGaD
Carbamazepine—Trimipramine—CYP2C9—brain cancer	0.000306	0.122	CrCbGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0003	0.00604	CbGpPWpGaD
Carbamazepine—Promethazine—CYP2C9—brain cancer	0.000294	0.117	CrCbGaD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000283	0.0057	CbGpPWpGaD
Carbamazepine—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000275	0.00555	CbGpPWpGaD
Carbamazepine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000274	0.00552	CbGpPWpGaD
Carbamazepine—RALBP1—telencephalon—brain cancer	0.000273	0.0506	CbGeAlD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.000272	0.00549	CbGpPWpGaD
Carbamazepine—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000272	0.00548	CbGpPWpGaD
Carbamazepine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00027	0.00545	CbGpPWpGaD
Carbamazepine—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000268	0.00541	CbGpPWpGaD
Carbamazepine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000262	0.00528	CbGpPWpGaD
Carbamazepine—Cardiac arrest—Etoposide—brain cancer	0.000261	0.00162	CcSEcCtD
Carbamazepine—Nausea—Lomustine—brain cancer	0.000261	0.00162	CcSEcCtD
Carbamazepine—Hypotension—Procarbazine—brain cancer	0.000261	0.00161	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Temozolomide—brain cancer	0.000259	0.00161	CcSEcCtD
Carbamazepine—Promazine—CYP2C9—brain cancer	0.000259	0.103	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—PCNA—brain cancer	0.000259	0.00521	CbGpPWpGaD
Carbamazepine—Stomatitis—Temozolomide—brain cancer	0.000258	0.0016	CcSEcCtD
Carbamazepine—Urinary tract infection—Temozolomide—brain cancer	0.000257	0.00159	CcSEcCtD
Carbamazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000256	0.00516	CbGpPWpGaD
Carbamazepine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000254	0.00157	CcSEcCtD
Carbamazepine—Insomnia—Procarbazine—brain cancer	0.000252	0.00156	CcSEcCtD
Carbamazepine—Paraesthesia—Procarbazine—brain cancer	0.00025	0.00155	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Temozolomide—brain cancer	0.00025	0.00155	CcSEcCtD
Carbamazepine—Sinusitis—Temozolomide—brain cancer	0.000248	0.00154	CcSEcCtD
Carbamazepine—Somnolence—Procarbazine—brain cancer	0.000248	0.00154	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000247	0.00153	CcSEcCtD
Carbamazepine—Cramp muscle—Etoposide—brain cancer	0.000247	0.00153	CcSEcCtD
Carbamazepine—Anaemia—Hydroxyurea—brain cancer	0.000244	0.00151	CcSEcCtD
Carbamazepine—Hallucination—Carmustine—brain cancer	0.000244	0.00151	CcSEcCtD
Carbamazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000244	0.00492	CbGpPWpGaD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000243	0.0049	CbGpPWpGaD
Carbamazepine—Decreased appetite—Procarbazine—brain cancer	0.000242	0.0015	CcSEcCtD
Carbamazepine—Oedema peripheral—Carmustine—brain cancer	0.000242	0.0015	CcSEcCtD
Carbamazepine—Connective tissue disorder—Carmustine—brain cancer	0.000241	0.0015	CcSEcCtD
Carbamazepine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000241	0.00486	CbGpPWpGaD
Carbamazepine—Fatigue—Procarbazine—brain cancer	0.00024	0.00149	CcSEcCtD
Carbamazepine—Constipation—Procarbazine—brain cancer	0.000238	0.00148	CcSEcCtD
Carbamazepine—Pain—Procarbazine—brain cancer	0.000238	0.00148	CcSEcCtD
Carbamazepine—Hepatitis—Temozolomide—brain cancer	0.000237	0.00147	CcSEcCtD
Carbamazepine—Dysphagia—Etoposide—brain cancer	0.000237	0.00147	CcSEcCtD
Carbamazepine—Leukopenia—Hydroxyurea—brain cancer	0.000237	0.00147	CcSEcCtD
Carbamazepine—Hallucination—Temozolomide—brain cancer	0.000236	0.00146	CcSEcCtD
Carbamazepine—Pharyngitis—Temozolomide—brain cancer	0.000236	0.00146	CcSEcCtD
Carbamazepine—Urinary tract disorder—Temozolomide—brain cancer	0.000234	0.00145	CcSEcCtD
Carbamazepine—Oedema peripheral—Temozolomide—brain cancer	0.000234	0.00145	CcSEcCtD
Carbamazepine—Connective tissue disorder—Temozolomide—brain cancer	0.000233	0.00145	CcSEcCtD
Carbamazepine—Urethral disorder—Temozolomide—brain cancer	0.000233	0.00144	CcSEcCtD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000231	0.00467	CbGpPWpGaD
Carbamazepine—Sweating increased—Etoposide—brain cancer	0.000231	0.00143	CcSEcCtD
Carbamazepine—Feeling abnormal—Procarbazine—brain cancer	0.00023	0.00142	CcSEcCtD
Carbamazepine—Eye disorder—Carmustine—brain cancer	0.000229	0.00142	CcSEcCtD
Carbamazepine—SCN9A—pituitary gland—brain cancer	0.000229	0.0426	CbGeAlD
Carbamazepine—Convulsion—Hydroxyurea—brain cancer	0.000229	0.00142	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Procarbazine—brain cancer	0.000228	0.00141	CcSEcCtD
Carbamazepine—Flushing—Carmustine—brain cancer	0.000228	0.00141	CcSEcCtD
Carbamazepine—Pancytopenia—Etoposide—brain cancer	0.000225	0.0014	CcSEcCtD
Carbamazepine—Erythema multiforme—Temozolomide—brain cancer	0.000224	0.00139	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000224	0.00139	CcSEcCtD
Carbamazepine—RALBP1—pituitary gland—brain cancer	0.000222	0.0412	CbGeAlD
Carbamazepine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000222	0.00447	CbGpPWpGaD
Carbamazepine—Eye disorder—Temozolomide—brain cancer	0.000222	0.00137	CcSEcCtD
Carbamazepine—Urticaria—Procarbazine—brain cancer	0.000222	0.00137	CcSEcCtD
Carbamazepine—Tinnitus—Temozolomide—brain cancer	0.000221	0.00137	CcSEcCtD
Carbamazepine—Body temperature increased—Procarbazine—brain cancer	0.00022	0.00137	CcSEcCtD
Carbamazepine—Abdominal pain—Procarbazine—brain cancer	0.00022	0.00137	CcSEcCtD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00022	0.00444	CbGpPWpGaD
Carbamazepine—Cardiac disorder—Temozolomide—brain cancer	0.00022	0.00136	CcSEcCtD
Carbamazepine—Flushing—Temozolomide—brain cancer	0.00022	0.00136	CcSEcCtD
Carbamazepine—Arrhythmia—Carmustine—brain cancer	0.000219	0.00136	CcSEcCtD
Carbamazepine—Alopecia—Carmustine—brain cancer	0.000217	0.00134	CcSEcCtD
Carbamazepine—Oedema—Hydroxyurea—brain cancer	0.000216	0.00134	CcSEcCtD
Carbamazepine—Angiopathy—Temozolomide—brain cancer	0.000215	0.00133	CcSEcCtD
Carbamazepine—Mental disorder—Carmustine—brain cancer	0.000215	0.00133	CcSEcCtD
Carbamazepine—Infection—Hydroxyurea—brain cancer	0.000214	0.00133	CcSEcCtD
Carbamazepine—Immune system disorder—Temozolomide—brain cancer	0.000214	0.00133	CcSEcCtD
Carbamazepine—RALBP1—medulla oblongata—brain cancer	0.000214	0.0398	CbGeAlD
Carbamazepine—Mediastinal disorder—Temozolomide—brain cancer	0.000214	0.00133	CcSEcCtD
Carbamazepine—Erythema—Carmustine—brain cancer	0.000214	0.00132	CcSEcCtD
Carbamazepine—Malnutrition—Carmustine—brain cancer	0.000214	0.00132	CcSEcCtD
Carbamazepine—Chills—Temozolomide—brain cancer	0.000213	0.00132	CcSEcCtD
Carbamazepine—Pneumonia—Etoposide—brain cancer	0.000213	0.00132	CcSEcCtD
Carbamazepine—Nervous system disorder—Hydroxyurea—brain cancer	0.000212	0.00131	CcSEcCtD
Carbamazepine—Infestation—Etoposide—brain cancer	0.000212	0.00131	CcSEcCtD
Carbamazepine—Infestation NOS—Etoposide—brain cancer	0.000212	0.00131	CcSEcCtD
Carbamazepine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000211	0.00131	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00021	0.0013	CcSEcCtD
Carbamazepine—Alopecia—Temozolomide—brain cancer	0.00021	0.0013	CcSEcCtD
Carbamazepine—Skin disorder—Hydroxyurea—brain cancer	0.00021	0.0013	CcSEcCtD
Carbamazepine—Renal failure—Etoposide—brain cancer	0.000208	0.00129	CcSEcCtD
Carbamazepine—Mental disorder—Temozolomide—brain cancer	0.000208	0.00129	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Etoposide—brain cancer	0.000207	0.00128	CcSEcCtD
Carbamazepine—Back pain—Carmustine—brain cancer	0.000207	0.00128	CcSEcCtD
Carbamazepine—Malnutrition—Temozolomide—brain cancer	0.000207	0.00128	CcSEcCtD
Carbamazepine—Erythema—Temozolomide—brain cancer	0.000207	0.00128	CcSEcCtD
Carbamazepine—Stomatitis—Etoposide—brain cancer	0.000206	0.00128	CcSEcCtD
Carbamazepine—Jaundice—Etoposide—brain cancer	0.000206	0.00128	CcSEcCtD
Carbamazepine—Anorexia—Hydroxyurea—brain cancer	0.000206	0.00127	CcSEcCtD
Carbamazepine—Hypersensitivity—Procarbazine—brain cancer	0.000205	0.00127	CcSEcCtD
Carbamazepine—SCN4A—pituitary gland—brain cancer	0.000205	0.038	CbGeAlD
Carbamazepine—Dysgeusia—Temozolomide—brain cancer	0.000202	0.00125	CcSEcCtD
Carbamazepine—SCN9A—midbrain—brain cancer	0.000202	0.0376	CbGeAlD
Carbamazepine—Vision blurred—Carmustine—brain cancer	0.000201	0.00125	CcSEcCtD
Carbamazepine—Tremor—Carmustine—brain cancer	0.0002	0.00124	CcSEcCtD
Carbamazepine—Asthenia—Procarbazine—brain cancer	0.0002	0.00124	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Etoposide—brain cancer	0.0002	0.00124	CcSEcCtD
Carbamazepine—Back pain—Temozolomide—brain cancer	0.0002	0.00124	CcSEcCtD
Carbamazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000198	0.00399	CbGpPWpGaD
Carbamazepine—Anaemia—Carmustine—brain cancer	0.000198	0.00122	CcSEcCtD
Carbamazepine—Agranulocytosis—Etoposide—brain cancer	0.000197	0.00122	CcSEcCtD
Carbamazepine—SCN9A—spinal cord—brain cancer	0.000197	0.0367	CbGeAlD
Carbamazepine—Pruritus—Procarbazine—brain cancer	0.000197	0.00122	CcSEcCtD
Carbamazepine—Agitation—Carmustine—brain cancer	0.000196	0.00122	CcSEcCtD
Carbamazepine—RALBP1—midbrain—brain cancer	0.000196	0.0364	CbGeAlD
Carbamazepine—Vision blurred—Temozolomide—brain cancer	0.000195	0.00121	CcSEcCtD
Carbamazepine—Tremor—Temozolomide—brain cancer	0.000194	0.0012	CcSEcCtD
Carbamazepine—Dyspnoea—Hydroxyurea—brain cancer	0.000192	0.00119	CcSEcCtD
Carbamazepine—Somnolence—Hydroxyurea—brain cancer	0.000192	0.00119	CcSEcCtD
Carbamazepine—Leukopenia—Carmustine—brain cancer	0.000191	0.00119	CcSEcCtD
Carbamazepine—RALBP1—spinal cord—brain cancer	0.000191	0.0355	CbGeAlD
Carbamazepine—Anaemia—Temozolomide—brain cancer	0.000191	0.00118	CcSEcCtD
Carbamazepine—Diarrhoea—Procarbazine—brain cancer	0.000191	0.00118	CcSEcCtD
Carbamazepine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00019	0.00384	CbGpPWpGaD
Carbamazepine—Dyspepsia—Hydroxyurea—brain cancer	0.00019	0.00118	CcSEcCtD
Carbamazepine—Agitation—Temozolomide—brain cancer	0.00019	0.00118	CcSEcCtD
Carbamazepine—Angioedema—Temozolomide—brain cancer	0.000189	0.00117	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—OR4C12—brain cancer	0.000188	0.0038	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—OR14C36—brain cancer	0.000188	0.0038	CbGpPWpGaD
Carbamazepine—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000188	0.00379	CbGpPWpGaD
Carbamazepine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000188	0.00379	CbGpPWpGaD
Carbamazepine—Decreased appetite—Hydroxyurea—brain cancer	0.000188	0.00116	CcSEcCtD
Carbamazepine—Urinary tract disorder—Etoposide—brain cancer	0.000188	0.00116	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000186	0.00115	CcSEcCtD
Carbamazepine—Urethral disorder—Etoposide—brain cancer	0.000186	0.00115	CcSEcCtD
Carbamazepine—Fatigue—Hydroxyurea—brain cancer	0.000186	0.00115	CcSEcCtD
Carbamazepine—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000186	0.00374	CbGpPWpGaD
Carbamazepine—Vertigo—Temozolomide—brain cancer	0.000186	0.00115	CcSEcCtD
Carbamazepine—Convulsion—Carmustine—brain cancer	0.000185	0.00115	CcSEcCtD
Carbamazepine—Leukopenia—Temozolomide—brain cancer	0.000185	0.00115	CcSEcCtD
Carbamazepine—Hypertension—Carmustine—brain cancer	0.000185	0.00114	CcSEcCtD
Carbamazepine—Constipation—Hydroxyurea—brain cancer	0.000185	0.00114	CcSEcCtD
Carbamazepine—Pain—Hydroxyurea—brain cancer	0.000185	0.00114	CcSEcCtD
Carbamazepine—Dizziness—Procarbazine—brain cancer	0.000184	0.00114	CcSEcCtD
Carbamazepine—Myalgia—Carmustine—brain cancer	0.000182	0.00113	CcSEcCtD
Carbamazepine—Chest pain—Carmustine—brain cancer	0.000182	0.00113	CcSEcCtD
Carbamazepine—Anxiety—Carmustine—brain cancer	0.000181	0.00112	CcSEcCtD
Carbamazepine—Erythema multiforme—Etoposide—brain cancer	0.00018	0.00111	CcSEcCtD
Carbamazepine—Convulsion—Temozolomide—brain cancer	0.000179	0.00111	CcSEcCtD
Carbamazepine—Hypertension—Temozolomide—brain cancer	0.000178	0.00111	CcSEcCtD
Carbamazepine—Feeling abnormal—Hydroxyurea—brain cancer	0.000178	0.0011	CcSEcCtD
Carbamazepine—Eye disorder—Etoposide—brain cancer	0.000177	0.0011	CcSEcCtD
Carbamazepine—CYP3A7—endocrine gland—brain cancer	0.000177	0.033	CbGeAlD
Carbamazepine—Vomiting—Procarbazine—brain cancer	0.000177	0.0011	CcSEcCtD
Carbamazepine—Cardiac disorder—Etoposide—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Flushing—Etoposide—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Confusional state—Carmustine—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Arthralgia—Temozolomide—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Myalgia—Temozolomide—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Rash—Procarbazine—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Dermatitis—Procarbazine—brain cancer	0.000176	0.00109	CcSEcCtD
Carbamazepine—Anxiety—Temozolomide—brain cancer	0.000175	0.00109	CcSEcCtD
Carbamazepine—Headache—Procarbazine—brain cancer	0.000175	0.00108	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000175	0.00108	CcSEcCtD
Carbamazepine—Oedema—Carmustine—brain cancer	0.000174	0.00108	CcSEcCtD
Carbamazepine—Infection—Carmustine—brain cancer	0.000173	0.00107	CcSEcCtD
Carbamazepine—Angiopathy—Etoposide—brain cancer	0.000172	0.00107	CcSEcCtD
Carbamazepine—Dry mouth—Temozolomide—brain cancer	0.000172	0.00107	CcSEcCtD
Carbamazepine—RALBP1—endocrine gland—brain cancer	0.000172	0.0319	CbGeAlD
Carbamazepine—UGT2B7—endocrine gland—brain cancer	0.000172	0.0319	CbGeAlD
Carbamazepine—Immune system disorder—Etoposide—brain cancer	0.000172	0.00106	CcSEcCtD
Carbamazepine—Mediastinal disorder—Etoposide—brain cancer	0.000171	0.00106	CcSEcCtD
Carbamazepine—Thrombocytopenia—Carmustine—brain cancer	0.000171	0.00106	CcSEcCtD
Carbamazepine—Body temperature increased—Hydroxyurea—brain cancer	0.000171	0.00106	CcSEcCtD
Carbamazepine—Chills—Etoposide—brain cancer	0.00017	0.00106	CcSEcCtD
Carbamazepine—Tachycardia—Carmustine—brain cancer	0.00017	0.00106	CcSEcCtD
Carbamazepine—Confusional state—Temozolomide—brain cancer	0.00017	0.00105	CcSEcCtD
Carbamazepine—RALBP1—head—brain cancer	0.00017	0.0315	CbGeAlD
Carbamazepine—Oedema—Temozolomide—brain cancer	0.000169	0.00104	CcSEcCtD
Carbamazepine—Anaphylactic shock—Temozolomide—brain cancer	0.000169	0.00104	CcSEcCtD
Carbamazepine—Alopecia—Etoposide—brain cancer	0.000168	0.00104	CcSEcCtD
Carbamazepine—Infection—Temozolomide—brain cancer	0.000167	0.00104	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—TRPC6—brain cancer	0.000167	0.00338	CbGpPWpGaD
Carbamazepine—Anorexia—Carmustine—brain cancer	0.000166	0.00103	CcSEcCtD
Carbamazepine—Nausea—Procarbazine—brain cancer	0.000166	0.00103	CcSEcCtD
Carbamazepine—Nervous system disorder—Temozolomide—brain cancer	0.000165	0.00102	CcSEcCtD
Carbamazepine—Thrombocytopenia—Temozolomide—brain cancer	0.000165	0.00102	CcSEcCtD
Carbamazepine—Skin disorder—Temozolomide—brain cancer	0.000164	0.00101	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	0.000163	0.00329	CbGpPWpGaD
Carbamazepine—Hypotension—Carmustine—brain cancer	0.000163	0.00101	CcSEcCtD
Carbamazepine—Hyperhidrosis—Temozolomide—brain cancer	0.000163	0.00101	CcSEcCtD
Carbamazepine—Dysgeusia—Etoposide—brain cancer	0.000162	0.001	CcSEcCtD
Carbamazepine—Anorexia—Temozolomide—brain cancer	0.000161	0.000996	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—DTX2—brain cancer	0.00016	0.00323	CbGpPWpGaD
Carbamazepine—Back pain—Etoposide—brain cancer	0.00016	0.000991	CcSEcCtD
Carbamazepine—Hypersensitivity—Hydroxyurea—brain cancer	0.000159	0.000985	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000159	0.000985	CcSEcCtD
Carbamazepine—Muscle spasms—Etoposide—brain cancer	0.000159	0.000985	CcSEcCtD
Carbamazepine—Insomnia—Carmustine—brain cancer	0.000158	0.000978	CcSEcCtD
Carbamazepine—Paraesthesia—Carmustine—brain cancer	0.000157	0.000971	CcSEcCtD
Carbamazepine—SCN4A—head—brain cancer	0.000156	0.0291	CbGeAlD
Carbamazepine—Dyspnoea—Carmustine—brain cancer	0.000156	0.000964	CcSEcCtD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000155	0.00313	CbGpPWpGaD
Carbamazepine—Somnolence—Carmustine—brain cancer	0.000155	0.000961	CcSEcCtD
Carbamazepine—RALBP1—central nervous system—brain cancer	0.000155	0.0288	CbGeAlD
Carbamazepine—Asthenia—Hydroxyurea—brain cancer	0.000155	0.00096	CcSEcCtD
Carbamazepine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000154	0.00311	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—TRPC6—brain cancer	0.000154	0.0031	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000154	0.0031	CbGpPWpGaD
Carbamazepine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000154	0.000952	CcSEcCtD
Carbamazepine—Anaemia—Etoposide—brain cancer	0.000153	0.000947	CcSEcCtD
Carbamazepine—Insomnia—Temozolomide—brain cancer	0.000152	0.000945	CcSEcCtD
Carbamazepine—Decreased appetite—Carmustine—brain cancer	0.000152	0.00094	CcSEcCtD
Carbamazepine—RALBP1—cerebellum—brain cancer	0.000151	0.0281	CbGeAlD
Carbamazepine—Paraesthesia—Temozolomide—brain cancer	0.000151	0.000938	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Carmustine—brain cancer	0.000151	0.000933	CcSEcCtD
Carbamazepine—Dyspnoea—Temozolomide—brain cancer	0.00015	0.000932	CcSEcCtD
Carbamazepine—Somnolence—Temozolomide—brain cancer	0.00015	0.000929	CcSEcCtD
Carbamazepine—Constipation—Carmustine—brain cancer	0.000149	0.000925	CcSEcCtD
Carbamazepine—Pain—Carmustine—brain cancer	0.000149	0.000925	CcSEcCtD
Carbamazepine—Vertigo—Etoposide—brain cancer	0.000149	0.00092	CcSEcCtD
Carbamazepine—Dyspepsia—Temozolomide—brain cancer	0.000148	0.00092	CcSEcCtD
Carbamazepine—Leukopenia—Etoposide—brain cancer	0.000148	0.000917	CcSEcCtD
Carbamazepine—Diarrhoea—Hydroxyurea—brain cancer	0.000148	0.000915	CcSEcCtD
Carbamazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000147	0.00296	CbGpPWpGaD
Carbamazepine—Decreased appetite—Temozolomide—brain cancer	0.000147	0.000908	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000146	0.000902	CcSEcCtD
Carbamazepine—Fatigue—Temozolomide—brain cancer	0.000145	0.000901	CcSEcCtD
Carbamazepine—Loss of consciousness—Etoposide—brain cancer	0.000145	0.0009	CcSEcCtD
Carbamazepine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000145	0.00292	CbGpPWpGaD
Carbamazepine—Constipation—Temozolomide—brain cancer	0.000144	0.000893	CcSEcCtD
Carbamazepine—Pain—Temozolomide—brain cancer	0.000144	0.000893	CcSEcCtD
Carbamazepine—Feeling abnormal—Carmustine—brain cancer	0.000144	0.000891	CcSEcCtD
Carbamazepine—Convulsion—Etoposide—brain cancer	0.000143	0.000888	CcSEcCtD
Carbamazepine—SCN4A—central nervous system—brain cancer	0.000143	0.0265	CbGeAlD
Carbamazepine—Hypertension—Etoposide—brain cancer	0.000143	0.000884	CcSEcCtD
Carbamazepine—Dizziness—Hydroxyurea—brain cancer	0.000143	0.000884	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Carmustine—brain cancer	0.000143	0.000884	CcSEcCtD
Carbamazepine—Chest pain—Etoposide—brain cancer	0.000141	0.000872	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00014	0.000866	CcSEcCtD
Carbamazepine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000139	0.00281	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Temozolomide—brain cancer	0.000139	0.000861	CcSEcCtD
Carbamazepine—Abdominal pain—Carmustine—brain cancer	0.000138	0.000855	CcSEcCtD
Carbamazepine—Body temperature increased—Carmustine—brain cancer	0.000138	0.000855	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Temozolomide—brain cancer	0.000138	0.000854	CcSEcCtD
Carbamazepine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000137	0.00277	CbGpPWpGaD
Carbamazepine—Vomiting—Hydroxyurea—brain cancer	0.000137	0.00085	CcSEcCtD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000137	0.00276	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000136	0.00274	CbGpPWpGaD
Carbamazepine—Rash—Hydroxyurea—brain cancer	0.000136	0.000843	CcSEcCtD
Carbamazepine—Confusional state—Etoposide—brain cancer	0.000136	0.000843	CcSEcCtD
Carbamazepine—Dermatitis—Hydroxyurea—brain cancer	0.000136	0.000843	CcSEcCtD
Carbamazepine—Headache—Hydroxyurea—brain cancer	0.000135	0.000838	CcSEcCtD
Carbamazepine—Anaphylactic shock—Etoposide—brain cancer	0.000135	0.000836	CcSEcCtD
Carbamazepine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000134	0.00271	CbGpPWpGaD
Carbamazepine—Infection—Etoposide—brain cancer	0.000134	0.000831	CcSEcCtD
Carbamazepine—Urticaria—Temozolomide—brain cancer	0.000134	0.00083	CcSEcCtD
Carbamazepine—Body temperature increased—Temozolomide—brain cancer	0.000133	0.000826	CcSEcCtD
Carbamazepine—Abdominal pain—Temozolomide—brain cancer	0.000133	0.000826	CcSEcCtD
Carbamazepine—Thrombocytopenia—Etoposide—brain cancer	0.000132	0.000819	CcSEcCtD
Carbamazepine—Tachycardia—Etoposide—brain cancer	0.000132	0.000816	CcSEcCtD
Carbamazepine—Skin disorder—Etoposide—brain cancer	0.000131	0.000812	CcSEcCtD
Carbamazepine—Hyperhidrosis—Etoposide—brain cancer	0.00013	0.000808	CcSEcCtD
Carbamazepine—Anorexia—Etoposide—brain cancer	0.000129	0.000797	CcSEcCtD
Carbamazepine—Hypersensitivity—Carmustine—brain cancer	0.000129	0.000797	CcSEcCtD
Carbamazepine—Nausea—Hydroxyurea—brain cancer	0.000128	0.000794	CcSEcCtD
Carbamazepine—SCN9A—brain—brain cancer	0.000127	0.0236	CbGeAlD
Carbamazepine—Hypotension—Etoposide—brain cancer	0.000126	0.000781	CcSEcCtD
Carbamazepine—Asthenia—Carmustine—brain cancer	0.000125	0.000776	CcSEcCtD
Carbamazepine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000125	0.00252	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000125	0.00251	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Temozolomide—brain cancer	0.000124	0.00077	CcSEcCtD
Carbamazepine—RALBP1—brain—brain cancer	0.000123	0.0228	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—PTCH2—brain cancer	0.000121	0.00245	CbGpPWpGaD
Carbamazepine—SCN5A—head—brain cancer	0.000121	0.0225	CbGeAlD
Carbamazepine—Paraesthesia—Etoposide—brain cancer	0.000121	0.000751	CcSEcCtD
Carbamazepine—Asthenia—Temozolomide—brain cancer	0.000121	0.00075	CcSEcCtD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000121	0.00243	CbGpPWpGaD
Carbamazepine—Dyspnoea—Etoposide—brain cancer	0.00012	0.000745	CcSEcCtD
Carbamazepine—Somnolence—Etoposide—brain cancer	0.00012	0.000743	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—TRPC6—brain cancer	0.00012	0.00241	CbGpPWpGaD
Carbamazepine—Diarrhoea—Carmustine—brain cancer	0.000119	0.00074	CcSEcCtD
Carbamazepine—Pruritus—Temozolomide—brain cancer	0.000119	0.000739	CcSEcCtD
Carbamazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000119	0.0024	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000118	0.00238	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HES5—brain cancer	0.000118	0.00237	CbGpPWpGaD
Carbamazepine—Decreased appetite—Etoposide—brain cancer	0.000117	0.000727	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Etoposide—brain cancer	0.000116	0.000722	CcSEcCtD
Carbamazepine—Fatigue—Etoposide—brain cancer	0.000116	0.000721	CcSEcCtD
Carbamazepine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000116	0.00234	CbGpPWpGaD
Carbamazepine—Dizziness—Carmustine—brain cancer	0.000115	0.000715	CcSEcCtD
Carbamazepine—Constipation—Etoposide—brain cancer	0.000115	0.000715	CcSEcCtD
Carbamazepine—Pain—Etoposide—brain cancer	0.000115	0.000715	CcSEcCtD
Carbamazepine—Diarrhoea—Temozolomide—brain cancer	0.000115	0.000715	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—STRADA—brain cancer	0.000114	0.0023	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—EGFR—brain cancer	0.000113	0.00229	CbGpPWpGaD
Carbamazepine—SCN4A—brain—brain cancer	0.000113	0.0211	CbGeAlD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000113	0.00228	CbGpPWpGaD
Carbamazepine—Dizziness—Temozolomide—brain cancer	0.000111	0.000691	CcSEcCtD
Carbamazepine—Feeling abnormal—Etoposide—brain cancer	0.000111	0.000689	CcSEcCtD
Carbamazepine—Vomiting—Carmustine—brain cancer	0.000111	0.000687	CcSEcCtD
Carbamazepine—SCN5A—central nervous system—brain cancer	0.000111	0.0206	CbGeAlD
Carbamazepine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000111	0.00223	CbGpPWpGaD
Carbamazepine—Gastrointestinal pain—Etoposide—brain cancer	0.00011	0.000684	CcSEcCtD
Carbamazepine—Rash—Carmustine—brain cancer	0.00011	0.000682	CcSEcCtD
Carbamazepine—Dermatitis—Carmustine—brain cancer	0.00011	0.000681	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—TRPC6—brain cancer	0.00011	0.00221	CbGpPWpGaD
Carbamazepine—Headache—Carmustine—brain cancer	0.000109	0.000677	CcSEcCtD
Carbamazepine—ABCB1—blood vessel—brain cancer	0.000108	0.0201	CbGeAlD
Carbamazepine—Vomiting—Temozolomide—brain cancer	0.000107	0.000664	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—brain cancer	0.000107	0.000664	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—brain cancer	0.000107	0.000661	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—brain cancer	0.000107	0.000661	CcSEcCtD
Carbamazepine—Rash—Temozolomide—brain cancer	0.000106	0.000659	CcSEcCtD
Carbamazepine—Dermatitis—Temozolomide—brain cancer	0.000106	0.000658	CcSEcCtD
Carbamazepine—Headache—Temozolomide—brain cancer	0.000106	0.000655	CcSEcCtD
Carbamazepine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000105	0.00212	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—TRPC6—brain cancer	0.000104	0.0021	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—EGFR—brain cancer	0.000104	0.0021	CbGpPWpGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.00209	CbGpPWpGaD
Carbamazepine—Nausea—Carmustine—brain cancer	0.000104	0.000642	CcSEcCtD
Carbamazepine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000102	0.00205	CbGpPWpGaD
Carbamazepine—Nausea—Temozolomide—brain cancer	0.0001	0.000621	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—brain cancer	9.94e-05	0.000616	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—brain cancer	9.68e-05	0.0006	CcSEcCtD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	9.62e-05	0.00194	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.59e-05	0.00193	CbGpPWpGaD
Carbamazepine—Pruritus—Etoposide—brain cancer	9.54e-05	0.000592	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—ABR—brain cancer	9.52e-05	0.00192	CbGpPWpGaD
Carbamazepine—Diarrhoea—Etoposide—brain cancer	9.23e-05	0.000572	CcSEcCtD
Carbamazepine—ABCC2—endocrine gland—brain cancer	9.22e-05	0.0171	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—GLI2—brain cancer	9.2e-05	0.00185	CbGpPWpGaD
Carbamazepine—CYP2C8—pituitary gland—brain cancer	8.93e-05	0.0166	CbGeAlD
Carbamazepine—Dizziness—Etoposide—brain cancer	8.92e-05	0.000553	CcSEcCtD
Carbamazepine—SCN5A—brain—brain cancer	8.79e-05	0.0163	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—GLI1—brain cancer	8.65e-05	0.00174	CbGpPWpGaD
Carbamazepine—Vomiting—Etoposide—brain cancer	8.58e-05	0.000532	CcSEcCtD
Carbamazepine—Rash—Etoposide—brain cancer	8.51e-05	0.000527	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—brain cancer	8.5e-05	0.000527	CcSEcCtD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	8.46e-05	0.0017	CbGpPWpGaD
Carbamazepine—Headache—Etoposide—brain cancer	8.45e-05	0.000524	CcSEcCtD
Carbamazepine—CYP2B6—gonad—brain cancer	8.21e-05	0.0153	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—SUFU—brain cancer	8.2e-05	0.00165	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.2e-05	0.00165	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.08e-05	0.00163	CbGpPWpGaD
Carbamazepine—Nausea—Etoposide—brain cancer	8.01e-05	0.000497	CcSEcCtD
Carbamazepine—CYP2C19—endocrine gland—brain cancer	7.92e-05	0.0147	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—GFAP—brain cancer	7.91e-05	0.00159	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HES1—brain cancer	7.7e-05	0.00155	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HEY1—brain cancer	7.5e-05	0.00151	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TRPC6—brain cancer	7.45e-05	0.0015	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—DLL1—brain cancer	7.35e-05	0.00148	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HES1—brain cancer	7.08e-05	0.00143	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—EGFR—brain cancer	7.07e-05	0.00143	CbGpPWpGaD
Carbamazepine—CYP2C8—endocrine gland—brain cancer	6.92e-05	0.0128	CbGeAlD
Carbamazepine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.54e-05	0.00132	CbGpPWpGaD
Carbamazepine—CYP1A2—endocrine gland—brain cancer	6.47e-05	0.012	CbGeAlD
Carbamazepine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.33e-05	0.00128	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SHH—brain cancer	6.25e-05	0.00126	CbGpPWpGaD
Carbamazepine—CYP3A5—endocrine gland—brain cancer	6.24e-05	0.0116	CbGeAlD
Carbamazepine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.24e-05	0.00126	CbGpPWpGaD
Carbamazepine—CYP2B6—endocrine gland—brain cancer	6.2e-05	0.0115	CbGeAlD
Carbamazepine—SCN9A—Axon guidance—ERBB2—brain cancer	6.19e-05	0.00125	CbGpPWpGaD
Carbamazepine—CYP2C9—endocrine gland—brain cancer	6.14e-05	0.0114	CbGeAlD
Carbamazepine—CYP2B6—head—brain cancer	6.12e-05	0.0114	CbGeAlD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.05e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CDK4—brain cancer	6.04e-05	0.00122	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TRPC6—brain cancer	6.03e-05	0.00122	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SMO—brain cancer	5.93e-05	0.00119	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTCH1—brain cancer	5.93e-05	0.00119	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—ERBB2—brain cancer	5.69e-05	0.00115	CbGpPWpGaD
Carbamazepine—CYP2B6—central nervous system—brain cancer	5.59e-05	0.0104	CbGeAlD
Carbamazepine—SCN4A—Developmental Biology—CDK4—brain cancer	5.55e-05	0.00112	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.46e-05	0.0011	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.33e-05	0.00107	CbGpPWpGaD
Carbamazepine—ABCB1—telencephalon—brain cancer	5.26e-05	0.00977	CbGeAlD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.17e-05	0.00104	CbGpPWpGaD
Carbamazepine—CYP2C8—brain—brain cancer	4.95e-05	0.00919	CbGeAlD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.88e-05	0.000983	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HES1—brain cancer	4.8e-05	0.000967	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—VEGFA—brain cancer	4.77e-05	0.000961	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NOTCH2—brain cancer	4.74e-05	0.000955	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP2C9—brain cancer	4.71e-05	0.00095	CbGpPWpGaD
Carbamazepine—CYP3A4—endocrine gland—brain cancer	4.68e-05	0.0087	CbGeAlD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.53e-05	0.000912	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.52e-05	0.000912	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VAV1—brain cancer	4.52e-05	0.000911	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.44e-05	0.000896	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—RELA—brain cancer	4.44e-05	0.000896	CbGpPWpGaD
Carbamazepine—CYP2B6—brain—brain cancer	4.44e-05	0.00825	CbGeAlD
Carbamazepine—SCN9A—Developmental Biology—ERBB2—brain cancer	4.41e-05	0.00089	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.39e-05	0.000886	CbGpPWpGaD
Carbamazepine—ABCB1—gonad—brain cancer	4.39e-05	0.00815	CbGeAlD
Carbamazepine—SCN4A—Axon guidance—VEGFA—brain cancer	4.38e-05	0.000883	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.37e-05	0.00088	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—brain cancer	4.29e-05	0.000865	CbGpPWpGaD
Carbamazepine—ABCB1—pituitary gland—brain cancer	4.28e-05	0.00795	CbGeAlD
Carbamazepine—CYP3A4—central nervous system—brain cancer	4.22e-05	0.00784	CbGeAlD
Carbamazepine—ABCB1—medulla oblongata—brain cancer	4.13e-05	0.00767	CbGeAlD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.09e-05	0.000825	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—RELA—brain cancer	4.08e-05	0.000823	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—ERBB2—brain cancer	4.06e-05	0.000818	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.04e-05	0.000814	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—BSG—brain cancer	4.01e-05	0.000807	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—brain cancer	3.94e-05	0.000794	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HES1—brain cancer	3.89e-05	0.000783	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CTNNB1—brain cancer	3.86e-05	0.000779	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—ERBB2—brain cancer	3.85e-05	0.000777	CbGpPWpGaD
Carbamazepine—ABCB1—midbrain—brain cancer	3.77e-05	0.00701	CbGeAlD
Carbamazepine—SCN5A—Developmental Biology—CDK4—brain cancer	3.76e-05	0.000759	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.73e-05	0.000753	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PDGFRA—brain cancer	3.7e-05	0.000746	CbGpPWpGaD
Carbamazepine—ABCB1—spinal cord—brain cancer	3.68e-05	0.00684	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—SPP1—brain cancer	3.59e-05	0.000724	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.59e-05	0.000723	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL2—brain cancer	3.57e-05	0.00072	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CTNNB1—brain cancer	3.55e-05	0.000716	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.52e-05	0.000709	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.5e-05	0.000706	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.47e-05	0.0007	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—IDH1—brain cancer	3.44e-05	0.000694	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.43e-05	0.000692	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—VEGFA—brain cancer	3.4e-05	0.000686	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—STAT3—brain cancer	3.37e-05	0.000679	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.36e-05	0.000677	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.36e-05	0.000677	CbGpPWpGaD
Carbamazepine—ABCB1—endocrine gland—brain cancer	3.32e-05	0.00616	CbGeAlD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.31e-05	0.000667	CbGpPWpGaD
Carbamazepine—ABCB1—head—brain cancer	3.27e-05	0.00608	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—IRS2—brain cancer	3.25e-05	0.000655	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.23e-05	0.000651	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP2C9—brain cancer	3.22e-05	0.000649	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.15e-05	0.000635	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—VEGFA—brain cancer	3.12e-05	0.00063	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—STAT3—brain cancer	3.09e-05	0.000624	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.08e-05	0.00062	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—brain cancer	3.06e-05	0.000617	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.03e-05	0.000612	CbGpPWpGaD
Carbamazepine—ABCB1—central nervous system—brain cancer	2.99e-05	0.00555	CbGeAlD
Carbamazepine—SCN5A—Axon guidance—VEGFA—brain cancer	2.97e-05	0.000598	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.95e-05	0.000595	CbGpPWpGaD
Carbamazepine—ABCB1—cerebellum—brain cancer	2.92e-05	0.00543	CbGeAlD
Carbamazepine—RALBP1—Signaling Pathways—APC—brain cancer	2.87e-05	0.000578	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CG—brain cancer	2.87e-05	0.000578	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—brain cancer	2.81e-05	0.000567	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—RELA—brain cancer	2.77e-05	0.000558	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—ERBB2—brain cancer	2.75e-05	0.000554	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—BSG—brain cancer	2.74e-05	0.000552	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ENO2—brain cancer	2.72e-05	0.000549	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.69e-05	0.000543	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—brain cancer	2.67e-05	0.000539	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.66e-05	0.000536	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.5e-05	0.000505	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CTNNB1—brain cancer	2.41e-05	0.000485	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.38e-05	0.00048	CbGpPWpGaD
Carbamazepine—ABCB1—brain—brain cancer	2.37e-05	0.00441	CbGeAlD
Carbamazepine—CYP3A7—Metabolism—IDH1—brain cancer	2.35e-05	0.000475	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP2C9—brain cancer	2.33e-05	0.000469	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.3e-05	0.000464	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—RELA—brain cancer	2.24e-05	0.000452	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—ERBB2—brain cancer	2.23e-05	0.000449	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—VEGFA—brain cancer	2.12e-05	0.000427	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—STAT3—brain cancer	2.1e-05	0.000423	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.09e-05	0.000421	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—BSG—brain cancer	2.02e-05	0.000408	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL2—brain cancer	2.02e-05	0.000407	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.02e-05	0.000406	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—BSG—brain cancer	1.98e-05	0.000399	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCND1—brain cancer	1.97e-05	0.000397	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CTNNB1—brain cancer	1.95e-05	0.000393	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.94e-05	0.000392	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—brain cancer	1.91e-05	0.000384	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—brain cancer	1.86e-05	0.000375	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000363	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2C9—brain cancer	1.76e-05	0.000354	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—IDH1—brain cancer	1.74e-05	0.000351	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.72e-05	0.000346	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFA—brain cancer	1.72e-05	0.000346	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—BSG—brain cancer	1.71e-05	0.000345	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—IDH1—brain cancer	1.7e-05	0.000343	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.7e-05	0.000343	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—STAT3—brain cancer	1.7e-05	0.000342	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—brain cancer	1.58e-05	0.000318	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—brain cancer	1.54e-05	0.000311	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—BSG—brain cancer	1.53e-05	0.000308	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.5e-05	0.000302	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—BSG—brain cancer	1.49e-05	0.000301	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—IDH1—brain cancer	1.47e-05	0.000297	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000283	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—BSG—brain cancer	1.39e-05	0.000281	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.38e-05	0.000278	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—brain cancer	1.38e-05	0.000277	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.35e-05	0.000272	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—brain cancer	1.34e-05	0.000271	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—IDH1—brain cancer	1.32e-05	0.000265	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—brain cancer	1.3e-05	0.000261	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—IDH1—brain cancer	1.28e-05	0.000259	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CG—brain cancer	1.25e-05	0.000252	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.2e-05	0.000242	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—IDH1—brain cancer	1.2e-05	0.000242	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BSG—brain cancer	1.19e-05	0.00024	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—brain cancer	1.16e-05	0.000235	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.13e-05	0.000228	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.08e-05	0.000218	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.07e-05	0.000216	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—brain cancer	1.04e-05	0.00021	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—IDH1—brain cancer	1.02e-05	0.000207	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—brain cancer	1.01e-05	0.000205	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.77e-06	0.000197	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—brain cancer	9.48e-06	0.000191	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BSG—brain cancer	9.2e-06	0.000185	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—brain cancer	8.54e-06	0.000172	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.35e-06	0.000168	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—brain cancer	8.1e-06	0.000163	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—IDH1—brain cancer	7.91e-06	0.000159	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—brain cancer	6.31e-06	0.000127	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—brain cancer	6.25e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—brain cancer	6.17e-06	0.000124	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.34e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.77e-06	9.62e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—brain cancer	4.66e-06	9.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.35e-06	8.77e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.72e-06	7.49e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.87e-06	5.78e-05	CbGpPWpGaD
